Medibio $0.001
(0.00%)
|
High $0.00 |
Low $0.00 |
Trades 6 |
Turnover $4,631 |
Volume 4,631,202 |
| 30 June 2023 at 3:48pm | ||||
MEDIBIO LIMITED
Health Care Equipment & Services
|
Market Cap (14-Nov) TBC |
Close (30-Jun) $0.001 |
Volume (30-Jun) 4,631,202 |
Shortsold (23-Jul) 66,820 (0.00%) (487th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS - |
FDA Confirm Diagnostic Method on Depression Validation Trial
MEB released this announcement to the ASX on 18 May 2022, 16:13. The announcement is marked as price sensitive, and is 1 page(s) in length and 218.87kb in size.
You can view all announcements from MEB and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from MEB | |
|---|---|
| Change of Director's Interest Notice - David Trimboli | 22 June 2023, 9:38 |
| Change of Director's Interest Notice - Chris Ntoumenopoulos | 22 June 2023, 9:37 |
| Notification regarding unquoted securities - MEB | 22 June 2023, 9:34 |
| FDA Confirm Diagnostic Method on Depression Validation Trial | 18 May 2022, 16:13 |
| 708A Cleansing Notice | 12 May 2022, 9:12 |
| Application for quotation of securities - MEB | 11 May 2022, 13:37 |
| Medibio Quarterly Update and Cashflow Report | 29 April 2022, 16:57 |
If you were already registered, log in here.
If you were already registered, log in here.